评论 2023 年颅内动脉瘤性蛛网膜下腔出血患者管理指南。
Comment on the 2023 Guidelines for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage.
机构信息
Department of Neurology (W.E.S., D.M.G., T.N.N.), Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, MA.
Neurosurgery (T.N.N.), Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, MA.
出版信息
Stroke. 2023 Oct;54(10):2708-2712. doi: 10.1161/STROKEAHA.123.043541. Epub 2023 Aug 15.
Aneurysmal subarachnoid hemorrhage can be a devastating disease, with an in-hospital mortality rate of up to 20%. The American Heart Association/American Stroke Association 2023 Aneurysmal Subarachnoid Hemorrhage Guidelines provide a comprehensive update to the 2012 Guidelines based on a systematic review of the intervening evidence. The guidelines are broad in scope, covering prehospital care, aneurysm treatment modality, medical complications, detection and treatment of delayed cerebral ischemia, and recovery. Here, we comment on salient aspects of aneurysmal subarachnoid hemorrhage care, compare these guidelines with the 2023 Neurocritical Care aneurysmal subarachnoid hemorrhage guidelines, and review relevant updates.
颅内动脉瘤性蛛网膜下腔出血是一种破坏性疾病，院内死亡率高达 20%。美国心脏协会/美国卒中协会 2023 年颅内动脉瘤性蛛网膜下腔出血指南基于对干预证据的系统回顾，对 2012 年指南进行了全面更新。该指南范围广泛，涵盖了院前护理、动脉瘤治疗方式、医疗并发症、迟发性脑缺血的检测和治疗以及康复。在这里，我们对颅内动脉瘤性蛛网膜下腔出血护理的重要方面进行了评论，比较了这些指南与 2023 年神经重症监护颅内动脉瘤性蛛网膜下腔出血指南，并回顾了相关更新。
Zotero 插件